Matt Dukewich, MD, PharmD

T32 GI/Liver Fellow, University of Southern California Clinical epidemiology, steatotic liver disease

[USC Division of GI & Liver @USC_KeckGILiver]

Multi-center ACCELERATE study led by USC GI fellow @MDukewich shows re-abstinence after alcohol relapse among LT recipients for AH can restore survival similar to w/o alcohol relapse.
-Take home message: detect early and treat relapse aggressively!
https://t.co/K8MuMN67Xq

[Matt Dukewich, MD, PharmD @MDukewich]

@drbobbybrown @AASLDtweets @HEP_Journal @LTxJournal @themayadeeb @IcahnMountSinai @KeckMedicineUSC @USC_KeckGILiver Thank you! I'm very excited to work with you and the team next year!

[Matt Dukewich, MD, PharmD @MDukewich]

RT @IASatUSC: Happy Friday Everyone! Congratulations to all of our ECASS 2024 participants and winners. What an amazing day full of novel a…

[Matt Dukewich, MD, PharmD @MDukewich]

@ebtapper Can we better connect SLD to the other manifestations of metabolic dysfunction, medically and culturally?
It feels like a huge missed opportunity that the liver is barely included in the new cardiac-kidney-metabolic syndrome discussion.

[AASLD @AASLDtweets]

Congratulations to our @HEP_Journal and @LTxJournal 2024 Editorial Fellows! @themayadeeb @IcahnMountSinai and @MDukewich @KeckMedicineUSC @USC_KeckGILiver #LiverTwitter

[Lily Dara @lilydaramd]

How big a problem is post LT EtOH use? @USC_KeckGILiver Drs. Brian P Lee and Matt Dukewich @MDukewich report data from the accelerate cohort: 80% pts remain abstinent post LT, of the 20% that relapse those that re-abstain and stop drinking for 12m after one relapse have good outcomes. Addiction is a chronic disease and we need to keep reinforcing the importance of #abstinence
@CLDFoundation #liverconnect @KeckMedicineUSC #livertwitter #gitwitter @AyyalaDivya @norahterrault @HelenHanMD @JeffreyAKahn @melanie_a_hundt @howiethedoc @kalizhouMD @AniKardashianMD